BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With GSK's €1.4Bn investment into acquiring CureVac's infectio
 us disease pipeline\, Moderna and BioNTech's initiation of personalised c
 ancer vaccine trials\, and the emergence of novel mRNA applications in pr
 otein replacement therapy\, gene editing and in vivo cell engineering\, t
 he mRNA industry is observing huge value R and D opportunities that will 
 open the floodgates towards clinical and market approval in 2025.\n\nThe 
 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt\, Germany 
 as the industry's premier forum dedicated to showcasing the hottest disea
 se targets\, never-before-seen pre-clinical and clinical data\, and demon
 strating key routes to commercial success for mRNA therapy and vaccine R 
 and D pipelines.\n\nWhether you're entering the mRNA arena for the first 
 time or a well-seasoned mRNA veteran\, with two dedicated tracks of conte
 nt spanning discovery through commercialisation\, this forum will equip y
 ou with the know-how and connections to make rapid advances in your work 
 with partnering and collaborative networking opportunities spread through
 out.\n\nAssembling 200+ mRNA enthusiasts from across Europe\, Asia and th
 e globe\, this is your one-stop-shop to gain unparalleled overview of cut
 ting-edge R and D innovations\, whilst diving deep into end-to-end develo
 pment strategy to revolutionise the next wave of mRNA medicines towards c
 linical reality.\n\n&nbsp\;\n\nDate and Time: On Tuesday January 28\, 202
 5 at 8:00 am to Thursday January 30\, 2025 at 5:00 pm\n\n&nbsp\;\n\nVenue
  details: Sheraton Frankfurt Airport Hotel and Conference Center\, 15 Hug
 o-Eckener-Ring\, Frankfurt am Main\, Hessen\, 60549\, Germany\n
DTEND:20250130T170000
DTSTAMP:20260512T232952Z
DTSTART:20250128T080000
LOCATION:Sheraton Frankfurt Airport Hotel and Conference Center\, 15 Hugo-
 Eckener-Ring\, Frankfurt am Main\, Hessen\, 60549\,
SEQUENCE:0
SUMMARY:With GSK's €1.4Bn investment into acquiring CureVac's infectious d
 isease pipeline\, Moderna and BioNTech's initiation of personalised cance
 r vaccine...
UID:97606815-8919-4f1d-9063-290f38935ccf
END:VEVENT
END:VCALENDAR
